Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice

Behavioural Brain Research

Volumn 286, Issue , 2015, Pages 356-363

  Nasehi, Mohammad ^a   Kafi, Faezeh ^b   Khakpai, Fatemeh ^c   Zarrindast, Mohammad Reza ^a,c,d,e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b KHARAZMI UNIVERSITY   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

ACPA; CA3; Memory; Mice; Serotonin

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 3 PIPERIDINOPROPYL ESTER; ARACHYDONILCYCLOPROPYLAMIDE; AZASETRON; CANNABINOID 1 RECEPTOR AGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG; 1-(3-CHLOROPHENYL)BIGUANIDE; 3-(PIPERIDINE-1-YL)PROPYL 4-AMINO-5-CHLORO-2-METHOXYBENZOATE HYDROCHLORIDE; 4 AMINOBENZOIC ACID DERIVATIVE; ANILINE DERIVATIVE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLCYCLOPROPYLAMIDE; BIGUANIDE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; FUSED HETEROCYCLIC RINGS; OXAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DRUG EFFECT; EXPLORATORY BEHAVIOR; HIPPOCAMPAL CA3 REGION; LOCOMOTION; MALE; MEMORY DISORDER; MICROINJECTION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; VENTRAL HIPPOCAMPUS; AGONISTS; ANIMAL; CHEMICALLY INDUCED; INDWELLING CATHETER; METABOLISM; PATHOPHYSIOLOGY;

AMNESIA; ANILINE COMPOUNDS; ANIMALS; ARACHIDONIC ACIDS; BICYCLO COMPOUNDS, HETEROCYCLIC; BIGUANIDES; CA3 REGION, HIPPOCAMPAL; CANNABINOID RECEPTOR AGONISTS; CATHETERS, INDWELLING; MALE; MICE; OXAZINES; PARA-AMINOBENZOATES; PIPERIDINES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, SEROTONIN, 5-HT3; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 84936994611     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.03.011     Document Type: Article

References (60)

1. Egashira N., Yano A., Ishigami N., Mishima K., Iwasaki K., Fujioka M., et al. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats. Brain Res 2006, 1069:54-62.
2. Huerta-Rivas A., Perez-Garcia G., Gonzalez-Espinosa C., Meneses A. Time-course of 5-HT(6) receptor mRNA expression during memory consolidation and amnesia. Neurobiol Learn Mem 2010, 93:99-110.
3. Bhatti A.S., Aydin C., Oztan O., Ma Z., Hall P., Tao R., et al. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT. Psychopharmacology (Berl) 2009, 203:23-32.
4. Senthilvelan M., Ravindran R., Samson J., Devi R.S. Serotonin turnover in different duration of sleep recovery in discrete regions of young rat brain after 24 h REM sleep deprivation. Brain Dev 2006, 28:526-528.
5. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 2006, 30:203-214.
6. Gonzalez-Burgos I., Feria-Velasco A. Serotonin/dopamine interaction in memory formation. Prog Brain Res 2008, 172:603-623.
7. Perez-Garcia G., Meneses A. Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia. Behav Brain Res 2008, 195:139-146.
8. Walstab J., Rappold G., Niesler B. 5-HT(3) receptors: role in disease and target of drugs. Pharmacol Ther 2010, 128:146-169.
9. Nedi T., White P.J., Coupar I.M., Irving H.R. Tissue dependent differences in G-protein coupled receptor kinases associated with 5-HT4 receptor desensitization in the rat gastro-intestinal tract. Biochem Pharmacol 2011, 81:123-133.
10. Charnay Y., Leger L. Brain serotonergic circuitries. Dialogues Clin Neurosci 2010, 12:471-487.
11. Berumen L.C., Rodriguez A., Miledi R., Garcia-Alcocer G. Serotonin receptors in hippocampus. ScientificWorldJournal 2012, 2012:823493.
12. Kulla A., Manahan-Vaughan D. Modulation by serotonin 5-HT(4) receptors of long-term potentiation and depotentiation in the dentate gyrus of freely moving rats. Cereb Cortex 2002, 12:150-162.
13. Ghiasvand M., Rezayof A., Zarrindast M.R., Ahmadi S. Activation of cannabinoid CB1 receptors in the central amygdala impairs inhibitory avoidance memory consolidation via NMDA receptors. Neurobiol Learn Mem 2011, 96:333-338.
14. Howlett A.C., Blume L.C., Dalton G.D. CB(1) cannabinoid receptors and their associated proteins. Curr Med Chem 2010, 17:1382-1393.
15. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat 2002, 68-69:619-631.
16. Garzon J., de la Torre-Madrid E., Rodriguez-Munoz M., Vicente-Sanchez A., Sanchez-Blazquez P. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Mol Pain 2009, 5:11.
17. Zavitsanou K., Wang H., Dalton V.S., Nguyen V. Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats. Neuroscience 2010, 169:315-324.
18. Nasehi M., Sahebgharani M., Haeri-Rohani A., Zarrindast M.R. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol Learn Mem 2009, 92:391-399.
19. Faerber L., Drechsler S., Ladenburger S., Gschaidmeier H., Fischer W. The neuronal 5-HT3 receptor network after 20 years of research - evolving concepts in management of pain and inflammation. Eur J Pharmacol 2007, 560:1-8.
20. Pamplona F.A., Takahashi R.N. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett 2006, 397:88-92.
21. Cammarota M., Bevilaqua L.R., Medina J.H., Izquierdo I. ERK1/2 and CaMKII-mediated events in memory formation: is 5HT regulation involved?. Behav Brain Res 2008, 195:120-128.
22. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press. 2nd edition.
23. Nasehi M., Amin Yavari S., Zarrindast M. Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology (Berl) 2013, 227:553-566.
24. Nasehi M., Mashaghi E., Khakpai F., Zarrindast M.R. Suggesting a possible role of CA1 Histaminergic system in Harmane-induced amnesia. Neurosci Lett 2013, 556:5-9.
25. Boissier J.R., Simon P. [The exploration reaction in the mouse. Preliminary note]. Therapie 1962, 17:1225-1232.
26. Zarrindast M.R., Nasehi M., Piri M., Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice. Pharmacol Biochem Behav 2010, 94:387-396.
27. Meneses A. Do serotonin(1-7) receptors modulate short and long-term memory?. Neurobiol Learn Mem 2007, 87:561-572.
28. Bert B., Fink H., Rothe J., Walstab J., Bonisch H. Learning and memory in 5-HT(1A)-receptor mutant mice. Behav Brain Res 2008, 195:78-85.
29. Gonzalez R., Chavez-Pascacio K., Meneses A. Role of 5-HT receptors in the consolidation of memory. Behav Brain Res 2013, 252C:246-251.
30. Meneses A., Perez-Garcia G. 5-HT(1A) receptors and memory. Neurosci Biobehav Rev 2007, 31:705-727.
31. Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev 1999, 23:1111-1125.
32. Meneses A. Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav Brain Res 2007, 184:81-90.
33. Meneses A. A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory. Learn Mem 2003, 10:363-372.
34. Perez-Garcia G., Meneses A. Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role. Behav Brain Res 2008, 195:17-29.
35. Pytliak M., Vargova V., Mechirova V., Felsoci M. Serotonin receptors - from molecular biology to clinical applications. Physiol Res 2011, 60:15-25.
36. Lamirault L., Simon H. Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors. Neuropharmacology 2001, 41:844-853.
37. Modica M., Santagati M., Guccione S., Russo F., Cagnotto A., Goegan M., et al. Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands. Eur J Med Chem 2000, 35:1065-1079.
38. Marchetti E., Dumuis A., Bockaert J., Soumireu-Mourat B., Roman F.S. Differential modulation of the 5-HT(4) receptor agonists and antagonist on rat learning and memory. Neuropharmacology 2000, 39:2017-2027.
39. Fakhfouri G., Rahimian R., Ghia J.E., Khan W.I., Dehpour A.R. Impact of 5-HT(3) receptor antagonists on peripheral and central diseases. Drug Discov Today 2012, 17:741-747.
40. Marchetti E., Jacquet M., Jeltsch H., Migliorati M., Nivet E., Cassel J.C., et al. Complete recovery of olfactory associative learning by activation of 5-HT4 receptors after dentate granule cell damage in rats. Neurobiol Learn Mem 2008, 90:185-191.
41. Micale V., Leggio G.M., Mazzola C., Drago F. Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res 2006, 1121:207-215.
42. Marchetti E., Jacquet M., Escoffier G., Miglioratti M., Dumuis A., Bockaert J., et al. Enhancement of reference memory in aged rats by specific activation of 5-HT(4) receptors using an olfactory associative discrimination task. Brain Res 2011, 1405:49-56.
43. Bockaert J., Claeysen S., Compan V., Dumuis A. 5-HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacology 2008, 55:922-931.
44. Petkov V.D., Belcheva S., Konstantinova E., Kehayov R. Participation of different 5-HT receptors in the memory process in rats and its modulation by the serotonin depletor p-chlorophenylalanine. Acta Neurobiol Exp (Warsz) 1995, 55:243-252.
45. Meneses A. Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav Brain Res 2004, 155:275-282.
46. Manuel-Apolinar L., Rocha L., Pascoe D., Castillo E., Castillo C., Meneses A. Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Brain Res 2005, 1042:73-81.
47. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
48. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 2004, 24:4787-4795.
49. Sullivan J.M. Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 2000, 7:132-139.
50. Heyser C.J., Hampson R.E., Deadwyler S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 1993, 264:294-307.
51. Nakamura E.M., da Silva E.A., Concilio G.V., Wilkinson D.A., Masur J. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend 1991, 28:167-175.
52. Ferrari F., Ottani A., Vivoli R., Giuliani D. Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacol Biochem Behav 1999, 64:555-561.
53. Kirby M.T., Hampson R.E., Deadwyler S.A. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus. Brain Res 2000, 863:120-131.
54. Kirby M.T., Hampson R.E., Deadwyler S.A. Cannabinoids selectively decrease paired-pulse facilitation of perforant path synaptic potentials in the dentate gyrus in vitro. Brain Res 1995, 688:114-120.
55. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
56. Hermann H., Marsicano G., Lutz B. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 2002, 109:451-460.
57. Devlin M.G., Christopoulos A. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum. J Neurochem 2002, 80:1095-1102.
58. Darmani N.A., Janoyan J.J., Kumar N., Crim J.L. Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover. Pharmacol Biochem Behav 2003, 75:777-787.
59. Egashira N., Mishima K., Katsurabayashi S., Yoshitake T., Matsumoto Y., Ishida J., et al. Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol 2002, 445:221-229.
60. Nakazi M., Bauer U., Nickel T., Kathmann M., Schlicker E. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 2000, 361:19-24.